{"entity":{"type":"insider","cik":"0001581992","url":"/insider/0001581992","json_url":"/insider/0001581992.json","name":"Goddard Glenn","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":38,"n_filings":26,"first":"2014-01-22","last":"2024-01-05","span_basis":"filed_date"},"name_variants":[{"name":"Goddard Glenn","source":"filing","n_filings":26,"first_seen":"2014-01-22","last_seen":"2024-01-05"}],"transactions":[{"id":3108020,"accession":"0000950170-24-002511","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-002511","line_url":"/filing/0000950170-24-002511#line-1","is_derivative":false,"issuer_cik":"0001581992","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001581992","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5365.0,"shares_display":"5,365","price_per_share":29.46,"price_display":"29.46","price_state":"stated","total_value":158052.9,"total_display":"158,052.90","total_whole":"158,053","shares_owned_after":40585.0,"shares_owned_after_display":"40,585","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-05","scope":"insider"},{"id":8214224,"accession":"0001209191-23-002414","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-002414","line_url":"/filing/0001209191-23-002414#line-1","is_derivative":false,"issuer_cik":"0001581992","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001581992","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2427.0,"shares_display":"2,427","price_per_share":37.21,"price_display":"37.21","price_state":"stated","total_value":90308.67,"total_display":"90,308.67","total_whole":"90,309","shares_owned_after":15404.0,"shares_owned_after_display":"15,404","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-06","scope":"insider"},{"id":6481724,"accession":"0001209191-22-015917","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-015917","line_url":"/filing/0001209191-22-015917#line-2","is_derivative":false,"issuer_cik":"0001581992","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001581992","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1013.0,"shares_display":"1,013","price_per_share":112.24,"price_display":"112.24","price_state":"stated","total_value":113699.12,"total_display":"113,699.12","total_whole":"113,699","shares_owned_after":2049.0,"shares_owned_after_display":"2,049","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-01","filed_date":"2022-03-03","scope":"insider"},{"id":4955837,"accession":"0001209191-21-055347","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-055347","line_url":"/filing/0001209191-21-055347#line-2","is_derivative":false,"issuer_cik":"0001581992","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001581992","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3482.0,"shares_display":"3,482","price_per_share":180.12,"price_display":"180.12","price_state":"stated","total_value":627177.84,"total_display":"627,177.84","total_whole":"627,178","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-07","filed_date":"2021-09-09","scope":"insider"},{"id":5499670,"accession":"0001209191-21-054315","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-21-054315","line_url":"/filing/0001209191-21-054315#line-12","is_derivative":false,"issuer_cik":"0001581992","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001581992","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24800.0,"shares_display":"24,800","price_per_share":160.22,"price_display":"160.22","price_state":"stated","total_value":3973456.0,"total_display":"3,973,456.00","total_whole":"3,973,456","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-31","filed_date":"2021-09-01","scope":"insider"},{"id":5499663,"accession":"0001209191-21-054315","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-21-054315","line_url":"/filing/0001209191-21-054315","is_derivative":false,"issuer_cik":"0001581992","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001581992","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5200.0,"shares_display":"5,200","price_per_share":155.78491538461537,"price_display":"155.78","price_state":"stated","total_value":810081.56,"total_display":"810,081.56","total_whole":"810,082","shares_owned_after":1696.0,"shares_owned_after_display":"1,696","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-30","filed_date":"2021-09-01","scope":"insider","n_lines":8},{"id":4623517,"accession":"0001209191-21-050225","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-050225","line_url":"/filing/0001209191-21-050225","is_derivative":false,"issuer_cik":"0001581992","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001581992","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":151.052804,"price_display":"151.05","price_state":"stated","total_value":3021056.08,"total_display":"3,021,056.08","total_whole":"3,021,056","shares_owned_after":10098.0,"shares_owned_after_display":"10,098","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-05","filed_date":"2021-08-06","scope":"insider","n_lines":3},{"id":8786253,"accession":"0001209191-15-072320","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-072320","line_url":"/filing/0001209191-15-072320#line-4","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":85.97,"price_display":"85.97","price_state":"stated","total_value":515820.0,"total_display":"515,820.00","total_whole":"515,820","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-24","filed_date":"2015-09-28","scope":"insider"},{"id":8675497,"accession":"0001209191-15-062574","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-062574","line_url":"/filing/0001209191-15-062574#line-3","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":120.45,"price_display":"120.45","price_state":"stated","total_value":843150.0,"total_display":"843,150.00","total_whole":"843,150","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-23","filed_date":"2015-07-27","scope":"insider"},{"id":8827393,"accession":"0001209191-15-061930","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-061930","line_url":"/filing/0001209191-15-061930#line-5","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":113.71,"price_display":"113.71","price_state":"stated","total_value":1478230.0,"total_display":"1,478,230.00","total_whole":"1,478,230","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-17","filed_date":"2015-07-21","scope":"insider"},{"id":8249766,"accession":"0001209191-15-047610","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-047610","line_url":"/filing/0001209191-15-047610#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2171.0,"shares_display":"2,171","price_per_share":120.05,"price_display":"120.05","price_state":"stated","total_value":260628.55,"total_display":"260,628.55","total_whole":"260,629","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-27","filed_date":"2015-05-28","scope":"insider"},{"id":8669634,"accession":"0001209191-15-027545","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-027545","line_url":"/filing/0001209191-15-027545#line-4","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":106.24,"price_display":"106.24","price_state":"stated","total_value":1062400.0,"total_display":"1,062,400.00","total_whole":"1,062,400","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-16","filed_date":"2015-03-18","scope":"insider"},{"id":8690685,"accession":"0001209191-15-014615","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-014615","line_url":"/filing/0001209191-15-014615#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1316.0,"shares_display":"1,316","price_per_share":120.31,"price_display":"120.31","price_state":"stated","total_value":158327.96,"total_display":"158,327.96","total_whole":"158,328","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-13","filed_date":"2015-02-17","scope":"insider"},{"id":8059400,"accession":"0001209191-15-012167","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-012167","line_url":"/filing/0001209191-15-012167#line-5","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1513.0,"shares_display":"1,513","price_per_share":120.14,"price_display":"120.14","price_state":"stated","total_value":181771.82,"total_display":"181,771.82","total_whole":"181,772","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-11","filed_date":"2015-02-11","scope":"insider"},{"id":8059394,"accession":"0001209191-15-012167","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-012167","line_url":"/filing/0001209191-15-012167#line-3","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":105.81,"price_display":"105.81","price_state":"stated","total_value":1587150.0,"total_display":"1,587,150.00","total_whole":"1,587,150","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-09","filed_date":"2015-02-11","scope":"insider"},{"id":6877982,"accession":"0001209191-14-066364","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-066364","line_url":"/filing/0001209191-14-066364#line-3","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":81.71,"price_display":"81.71","price_state":"stated","total_value":163420.0,"total_display":"163,420.00","total_whole":"163,420","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-03","filed_date":"2014-11-04","scope":"insider"},{"id":7075195,"accession":"0001209191-14-061799","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-061799","line_url":"/filing/0001209191-14-061799#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":60.07,"price_display":"60.07","price_state":"stated","total_value":90105.0,"total_display":"90,105.00","total_whole":"90,105","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-01","filed_date":"2014-10-03","scope":"insider"},{"id":7015705,"accession":"0001209191-14-060121","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-060121","line_url":"/filing/0001209191-14-060121#line-4","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17500.0,"shares_display":"17,500","price_per_share":56.53,"price_display":"56.53","price_state":"stated","total_value":989275.0,"total_display":"989,275.00","total_whole":"989,275","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-26","filed_date":"2014-09-29","scope":"insider"},{"id":6737795,"accession":"0001209191-14-055719","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-055719","line_url":"/filing/0001209191-14-055719#line-3","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":46.3,"price_display":"46.30","price_state":"stated","total_value":463000.0,"total_display":"463,000.00","total_whole":"463,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-02","filed_date":"2014-09-03","scope":"insider"},{"id":6678487,"accession":"0001209191-14-045511","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-045511","line_url":"/filing/0001209191-14-045511#line-4","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":46.52,"price_display":"46.52","price_state":"stated","total_value":162820.0,"total_display":"162,820.00","total_whole":"162,820","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-01","filed_date":"2014-07-02","scope":"insider"},{"id":7000152,"accession":"0001209191-14-031227","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-031227","line_url":"/filing/0001209191-14-031227#line-4","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":42.39,"price_display":"42.39","price_state":"stated","total_value":84780.0,"total_display":"84,780.00","total_whole":"84,780","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-01","filed_date":"2014-05-05","scope":"insider"},{"id":6317813,"accession":"0001209191-14-026528","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-026528","line_url":"/filing/0001209191-14-026528#line-3","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":45.17,"price_display":"45.17","price_state":"stated","total_value":90340.0,"total_display":"90,340.00","total_whole":"90,340","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-07","filed_date":"2014-04-08","scope":"insider"},{"id":6526087,"accession":"0001209191-14-025630","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-025630","line_url":"/filing/0001209191-14-025630#line-3","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":38.08,"price_display":"38.08","price_state":"stated","total_value":152320.0,"total_display":"152,320.00","total_whole":"152,320","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-01","filed_date":"2014-04-03","scope":"insider"},{"id":6613618,"accession":"0001209191-14-018505","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-14-018505","line_url":"/filing/0001209191-14-018505#line-5","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":45.1,"price_display":"45.10","price_state":"stated","total_value":541200.0,"total_display":"541,200.00","total_whole":"541,200","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-07","filed_date":"2014-03-07","scope":"insider"},{"id":6613609,"accession":"0001209191-14-018505","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-018505","line_url":"/filing/0001209191-14-018505#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5468.0,"shares_display":"5,468","price_per_share":35.54,"price_display":"35.54","price_state":"stated","total_value":194332.72,"total_display":"194,332.72","total_whole":"194,333","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-06","filed_date":"2014-03-07","scope":"insider"},{"id":6943313,"accession":"0001209191-14-012651","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-012651","line_url":"/filing/0001209191-14-012651#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3532.0,"shares_display":"3,532","price_per_share":35.06,"price_display":"35.06","price_state":"stated","total_value":123831.92,"total_display":"123,831.92","total_whole":"123,832","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-18","filed_date":"2014-02-20","scope":"insider"},{"id":6522034,"accession":"0001209191-14-009242","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-009242","line_url":"/filing/0001209191-14-009242#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":30.44,"price_display":"30.44","price_state":"stated","total_value":182640.0,"total_display":"182,640.00","total_whole":"182,640","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-10","filed_date":"2014-02-11","scope":"insider"},{"id":6754527,"accession":"0001209191-14-005331","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-005331","line_url":"/filing/0001209191-14-005331#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":26.293,"price_display":"26.29","price_state":"stated","total_value":184051.0,"total_display":"184,051.00","total_whole":"184,051","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-27","filed_date":"2014-01-28","scope":"insider"},{"id":6731199,"accession":"0001209191-14-004379","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-004379","line_url":"/filing/0001209191-14-004379#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581992","owner_name":"Goddard Glenn","owner_display_name":"Goddard Glenn","owner_url":"/insider/0001581992","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":34.7108,"price_display":"34.71","price_state":"stated","total_value":347108.0,"total_display":"347,108.00","total_whole":"347,108","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-21","filed_date":"2014-01-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":38,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":38,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":38},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001652130","name":"Intellia Therapeutics, Inc.","url":"/issuer/0001652130","role":"Officer (EVP, Chief Financial Officer)","n_filings":6,"first_seen":"2021-08-06","last_seen":"2024-01-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001439222","name":"AGIOS PHARMACEUTICALS INC","url":"/issuer/0001439222","role":"Officer (Senior Vice President, Finance)","n_filings":20,"first_seen":"2014-01-22","last_seen":"2015-09-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001581992","retrieved_at":"2026-08-22T17:42:25+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}